The Effect of Oxygen Given to Patients in the Postoperative Period on Nausea and Vomiting
1 other identifier
interventional
111
1 country
1
Brief Summary
Carbon dioxide which is insufflated to inflate the abdominal area is absorbed from the peritoneal area and it increases endogenous catecholamines, which may consequently increase nausea and vomiting. In the literature, it is indicated that oxygen application which is one of the applications aiming to prevent nausea and vomiting is a cheap method with fewer side effects in the prevention of postoperative nausea and vomiting. In the literature, studies on the prevention of nausea and vomiting by oxygen application in different surgical interventions have not arrived at a consensus regarding surgery type and oxygen amounts. There are studies evaluating 80% and 30% oxygen amounts in removing postoperative nausea and vomiting. Taking these conditions into consideration; the study has been planned for the purpose of examining the impact of giving 80% and 60% oxygen to patients to whom laparoscopic cholecystectomy is applied on postoperative nausea and vomiting in the postoperative period. The study has been planned as a randomized controlled study for the purpose of determining the impact of giving oxygen (80% to the group A, 60% to the group B and control group C) to patients who apply to the general surgery service to undergo a laparoscopic cholecystectomy on postoperative nausea and vomiting in the postoperative period. The patients in the study will have the same standard anesthesia protocol and hospital routine. The study will be terminated once a total of 111 patients have been reached. In the study randomization, the patients will be assigned to the sample group according to weeks as they may influence each other. Data will be collected using Patient Introductory Information Form, which evaluates patients' socio-demographic characteristics, as well as Perioperative Period Patient Follow-Up Form and Postoperative Period Nausea-Vomiting Frequency and Severity Evaluation Form. Statistical analysis of the data to be acquired as a result of the study will be performed in the computer environment. The results to be obtained will be evaluated at p\<0,05 significance level. It is expected that the study results will provide an alternative method, which will be used in preventing the possible side effects of postoperative nausea and vomiting in patients who undergo a laparoscopic cholecystectomy. Thus, the study results may make scientific and socio-economic contributions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2022
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2023
CompletedOctober 22, 2020
October 1, 2020
8 months
October 15, 2020
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
severity of nausea
severity of nausea was measured using a 10-cm visual analog scale, The patients were explained that 1 point indicated "no nausea" and 10 points indicated "severe nausea," and then they were asked to give 1-10 points for their severity of nausea.
0-24 hours in the postoperative period
severity of vomiting
severity of vomiting was measured using a 10-cm visual analog scale, The patients were explained that 1 point indicated "no vomiting" and 10 points indicated "severe vomiting," and then they were asked to give 1-10 points for their severity of vomiting
0-24 hours in the postoperative period
Study Arms (3)
80% oxygen
EXPERIMENTAL80% oxygen given group
60% oxygen
EXPERIMENTAL60% oxygen given group
routine hospital care
NO INTERVENTIONThe patients in this group received routine hospital care.
Interventions
Eligibility Criteria
You may qualify if:
- Surgery time is 2 hours or less
- The patient does not have peripheral vascular disease
- The patient does not have a psychiatric disorder
- The patient can communicate verbally
- The patient is not using anticoagulant drugs
- The patient's hemoglobin level in the preoperative period is in the range of 12-16 g / dL
- The patient's American Society of Anesthesiologist (ASA) value is between 1-2
- The patient is not smoking
- The patient is between 18 and 65 years old
- In the intraoperative period, the carbon dioxide gas pressure used to inflate the abdomen is between 10-12.
- The patient's willingness to participate in the research
- The patient does not have respiratory diseases (such as bronchitis)
- The patient does not have claustrophobia
You may not qualify if:
- \- The patient is using anticoagulant medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pınar tunç tuna
Konya, 42500, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hulya Bulut
Gazi University
- STUDY CHAIR
Sevil Guler Demir
Gazi University
- STUDY CHAIR
Faruk Cicekci
Selcuk University
- STUDY CHAIR
Hulagu Barıskaner
Selcuk University
- STUDY CHAIR
Mustafa Sahin
Selcuk University
- STUDY CHAIR
Inci Kara
Selcuk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 22, 2020
Study Start
May 3, 2022
Primary Completion
January 3, 2023
Study Completion
May 3, 2023
Last Updated
October 22, 2020
Record last verified: 2020-10